UNITY BIOTECHNOLOGY, INC. AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into effective as of March 9, 2020 (the “Effective Date”), by and between Unity Biotechnology, Inc., a Delaware corporation (“Company”) and Tamara L. Tompkins (“Executive”).
SECOND AMENDMENT TO COMPOUND LICENSE AGREEMENT FOR APG-1197Compound License Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
This second amendment (the “Second Amendment”), dated as of January 8, 2020 (the “Amendment Effective Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 3280 Bayshore Blvd, Suite 100, Brisbane, California 95002. Ascentage and Unity are sometimes referred to herein as individually as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT TO APG1252 LICENSE AGREEMENTApg1252 License Agreement • March 11th, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations
This Amendment (the “Second Amendment”), dated as of November 19, 2019 (the “Second Amendment Effective Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 3280 Bayshore Blvd, Suite 100, Brisbane, California 95002. Ascentage and Unity are sometimes referred to herein as individually as a “Party” and collectively as the “Parties”.
